Super Micro Computer cut its revenue outlook for its fiscal first quarter after some customers delayed taking delivery of their orders. Shares fell 8.5% Thursday to $48.05. The stock is down more than ...

Super Micro Computer trimmed its first-quarter revenue forecast on Thursday, citing a shift in customer delivery schedules ...

President Donald Trump recently announced a new deal with Pfizer to sell its drugs directly to consumers at discounted prices on a government-run website called 'TrumpRx.' Social Security, Medicare ...

The 2026 IONIQ 5 is slated for a significant price cut as Hyundai commits to offering more affordable vehicles in the US. Hyundai said it will reduce prices by up to $9,800 on the 2026 IONIQ 5. The ...

Bitcoin's post-shutdown surge doesn't necessarily make it a safe-haven asset. Markets are extremely confident about an October rate cut, which could boost crypto prices. A lengthy shutdown could dent ...

Shares of the global tech company jumped 9.30%, rising by $4.46 to finish at $52.40 during regular trading on Wednesday. This marks the third day in a row the stock has been on the rise. The stock ...

WASHINGTON >> Pfizer and President Donald Trump on Tuesday said they had cut a deal in which the U.S.-based drugmaker agreed to lower prescription drug prices in the Medicaid program to what it ...

Nisha Gopalan is a former Senior Overnight Assignment Editor for Investopedia News. She is an award-winning financial journalist who has worked in London, where she is currently based, and Hong Kong.

Pfizer Inc. secured a reprieve from President Donald Trump’s long-threatened tariffs on the pharmaceutical industry Tuesday by agreeing to slash some of its drug prices by up to 85% and selling ...

U.S. home prices continued to rise at a slower pace in July in a fresh sign of summer weakness in the housing market. The S&P Cotality Case-Shiller National Home Price Index, which measures home ...

In an expansion of its previous moves to cut insulin prices, Sanofi will cap the price of each of its insulin products at $35 per month in the U.S. regardless of a patient's insurance status. The move ...